ELQ-453
ELQ-453 is an inhibitor that targets the Qo site of the cytochrome bc1 complex (CytB) in the malignant Plasmodium falciparum, with an IC50 value of 0.57 μM. ELQ-453 disrupts mitochondrial function in parasites and prevents Plasmodium infection in mosquitoes, showing promise for malaria research.
Product Specifications
Field of Research
Infectious Disease & Virology, Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1358631-01 0.02 mg (E-Coli)
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF8 (RNF8)
Sign In for Pricing
View Details MBS1358631-02 0.02 mg (Yeast)
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF8 (RNF8)
Sign In for Pricing
View Details MBS1358631-03 0.1 mg (E-Coli)
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF8 (RNF8)
Sign In for Pricing
View Details MBS1358631-04 0.1 mg (Yeast)
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF8 (RNF8)
Sign In for Pricing
View Details MBS1358631-05 0.02 mg (Baculovirus)
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF8 (RNF8)
Sign In for Pricing
View Details MBS1358631-06 0.02 mg (Mammalian-Cell)
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF8 (RNF8)
Sign In for Pricing
View Details